Skip to main content
Clinical Trials/EUCTR2011-000257-23-GB
EUCTR2011-000257-23-GB
Active, not recruiting
Not Applicable

A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin® Once liquid gel compared with Lyclear 1% permethrin crème rinse in the treatment of head lice - Hedrin Once versus Lyclear against head lice

Thornton & Ross Ltd0 sites84 target enrollmentMay 3, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Head louse infestation (pediculosis capitis)
Sponsor
Thornton & Ross Ltd
Enrollment
84
Status
Active, not recruiting
Last Updated
13 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 3, 2011
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Children and adults aged 6 months and over of both sexes with no upper age limit.
  • 2\. People who upon examination, are confirmed to have live head lice.
  • 3\. People who give written informed consent or, if the participant is under 16 years of age, whose parent/guardian gives written informed consent to participate in the study.
  • 4\. People who will be available for follow up visits by study team members over the 14 days following first treatment.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. People with a known sensitivity to any of the ingredients in Hedrin Once liquid gel or Lyclear 1% permethin creme rinse.
  • 2\. People with a bacterial infection of the scalp (e.g. impetigo) or who have an active long term scalp condition (e.g. psoriasis of the scalp).
  • 3\. People who have been treated with other head lice products within the previous two weeks.
  • 4\. People who have been treated with the antibiotics CoTrimoxazole or Trimethoprim within the previous four weeks, or who are currently taking such a course.
  • 5\. Pregnant or nursing mothers.
  • 6\. People who have participated in another clinical study within 1 month before entry to this study.
  • 7\. People who have already participated in this clinical study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin 4% dimeticone lotion compared with Derbac-M 0.5% malathion aqueous liquid in the treatment of head lice
ISRCTN47755726Thornton & Ross Ltd (UK)73
Active, not recruiting
Phase 1
A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin 4% dimeticone lotion compared with Derbac-M 0.5% malathion aqueous liquid in the treatment of head lice - Is Hedrin 4% more effective than Derbac-M for the treatment of head lice?
EUCTR2006-004136-73-GBThornton & Ross Limited
Active, not recruiting
Not Applicable
A randomised, controlled, assessor-blind, clinical trial to compare Liceko ® with NIX/Lyclear 1% permethrin crème rinse in the treatment of head lice. - Is Liceko ® more effective than Lyclear against head lice?
EUCTR2011-001892-38-GBPanin S.r.l.44
Completed
Not Applicable
Is Liceko® more effective than Nix® / Lyclear® against head lice?Head louse infestationInfections and InfestationsPediculosis due to Pediculus humanus capitis
ISRCTN45553737Panin S.R.L (Italy)44
Active, not recruiting
Phase 1
A randomised, controlled, assessor-blind, clinical investigation of the activity of mosquito® LäuseShampoo compared with Infectopedicul® permethrin 0.5% lotion in the treatment of head lice - Comparing mosquito LauseShampoo with Infectopedicul lotioInfestation by head lice (pediculosis capitis)MedDRA version: 9.1 Level: LLT Classification code 10019199 Term: Head pediculosis
EUCTR2010-019804-21-GBWepa Apothekenbedarf GmbH & Co KG96